Fracture rates higher in patients with HIV

Michael Carter
Published: 15 March 2011

Fracture rates in patients with HIV are higher than those in the general US population, investigators report in the online edition of Clinical Infectious Diseases. Rates increased between 2000 and 2002, and then remained broadly stable until the end of the study in 2008.

“Age-adjusted fracture rates among men and women aged 25-54 years in the HOPS [HIV Outpatient Study] were consistently higher than those in adults in the US general population.”

Older age was significantly associated with an increased risk of fracture, as were substance abuse, co-infection with hepatitis C virus, diabetes and a nadir CD4 cell count below 200 cells/mm3.

The investigators believe that their results have clinical significance and call for HIV care to routinely consider patients’ risk of fractures and falls.

Low bone mineral density is common in patients with HIV, and some studies have suggested that fracture rates are increasing in this group.

Researchers from HOPS wanted to get a clearer understanding of fracture rates in patients with HIV.

They therefore compared fracture rates seen in 5826 patients who received care between 2000 and 2008 with those recorded in the general US population.

Data were also gathered on rates of fragility fractures (wrist, vertebra, hip), and the investigators conducted analyses to see if any factors were associated with an increased risk of fracture for patients with HIV.

Most (79%) of the patients were male, their median age was 40, over half (52%) were white, and 73% were taking antiretroviral therapy.

A total of 233 patients experienced a fracture. Fracture rates increased from 57 per 1000 person years in 2000 to 85 per 1000 person years in 2002. This increase was significant (p = 0.01).

Rates then remained broadly stable until the end of follow-up in 2008 (90 per 1000 person years).

In contrast, no change was observed in the fracture rate for the general US population between 2000 and 2006.

Patients aged between 25 and 54 constituted 87% of the HOPS population, and a significant increase in fracture rates (p = 0.01) was observed in these individuals over the course of the study.

Rates of fragility fractures were higher among both HIV-positive men and women than age-matched controls in the general US population.

HIV-positive men were significantly more likely to experience fractures of the wrist and vertebra (p < 0.01), and HIV-positive women experienced more fractures of the vertebra (p < 0.01) and hip (p = 0.04). 

Analysis showed that factors associated with an increased risk of fracture for patients with HIV were age over 47 (p = 0.05), a nadir CD4 cell count below 200 cells/mm3, co-infection with hepatitis C (p = 0.01), diabetes (p = 0.05) and substance abuse (p = 0.05).

Many of these are known risk factors for fracture.

However, the investigators note that the association with nadir CD4 cell count is new and unexplained and call for further studies to examine this association.

Risk factors for fragility fractures also included age and hepatitis C co-infection, as well as a body mass index (BMI) below 18.5 (adjusted hazard ratio, 3.72; 95% CI, 1.14-12.09).

“Our study suggests that HIV-infected adults, particularly adults aged 25-54 years, are at an increased risk of bone fracture, compared with the general population,” conclude the investigators.

They believe that their findings have implications for HIV care, commenting, “we recommend that screening for and correcting reversible causes of low BMD [bone mineral density] and fall risk be incorporated into routine clinical care of HIV-infected patients.”

Reference

Young B et al. Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000-2006. Clin Infect Dis, online edition: doi: 10.1093/cid/ciq242, 2011 (click here for the free abstract).

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.